Video

Dr. Sonpavde on real-world treatment patterns and outcomes with frontline therapy in advanced urothelial carcinoma

Guru P. Sonpavde, MD, director of the Bladder Cancer Program at Dana-Farber Cancer Institute, and associate professor of Medicine at Harvard Medical School, discusses the 2022 ASCO Annual Meeting abstract, “Real-world treatment patterns and clinical outcomes with first-line therapy in cisplatin-eligible and ineligible patients with advanced urothelial carcinoma.”

Related Videos
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
4 experts in this video
4 experts in this video
Female doctor typing on her laptop computer in medical office | Image Credit: © Rostislav Sedlacek - stock.adobe.com
4 experts in this video
4 experts in this video
Rebecca A. Campbell, MD, answers a question during a Zoom video interview
Related Content
© 2025 MJH Life Sciences

All rights reserved.